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Summary
Background In patients with chronic spinal cord injury, imaging of the spinal cord and brain above the level of the 
lesion provides evidence of neural degeneration; however, the spatial and temporal patterns of progression and their 
relation to clinical outcomes are uncertain. New interventions targeting acute spinal cord injury have entered clinical 
trials but neuroimaging outcomes as responsive markers of treatment have yet to be established. We aimed to use 
MRI to assess neuronal degeneration above the level of the lesion after acute spinal cord injury. 
Methods In our prospective longitudinal study, we enrolled patients with acute traumatic spinal cord injury and 
healthy controls. We assessed patients clinically and by MRI at baseline, 2 months, 6 months, and 12 months, and 
controls by MRI at the same timepoints. We assessed atrophy in white matter in the cranial corticospinal tracts and 
grey matter in sensorimotor cortices by tensor-based analyses of T1-weighted MRI data. We used cross-sectional 
spinal cord area measurements to assess atrophy at cervical level C2/C3. We used myelin-sensitive magnetisation 
transfer (MT) and longitudinal relaxation rate (R1) maps to assess microstructural changes associated with myelin. 
We also assessed associations between MRI parameters and clinical improvement. All analyses of brain scans done 
with statistical parametric mapping were corrected for family-wise error.
Findings Between Sept 17, 2010, and Dec 31, 2012, we recruited 13 patients and 18 controls. In the 12 months from 
baseline, patients recovered by a mean of 5·27 points per log month (95% CI 1·91–8·63) on the international 
standards for the neurological classiﬁ cation of spinal cord injury (ISNCSCI) motor score (p=0·002) and by 
10·93 points per log month (6·20–15·66) on the spinal cord independence measure (SCIM) score (p<0·0001). 
Compared with controls, patients showed a rapid decline in cross-sectional spinal cord area (patients declined by 
0·46 mm per month compared with a stable cord area in controls; p<0·0001). Patients had faster rates than controls 
of volume decline of white matter in the cranial corticospinal tracts at the level of the internal capsule (right 
Z score 5·21, p=0·0081; left Z score 4·12, p=0·0004) and right cerebral peduncle (Z score 3·89, p=0·0302) and of 
grey matter in the left primary motor cortex (Z score 4·23, p=0·041). Volume changes were paralleled by signiﬁ cant 
reductions of MT and R1 in the same areas and beyond. Improvements in SCIM scores at 12 months were associated 
with a reduced loss in cross-sectional spinal cord area over 12 months (Pearson’s correlation 0·77, p=0·004) and 
reduced white matter volume of the corticospinal tracts at the level of the right internal capsule (Z score 4·30, 
p=0·0021), the left internal capsule (Z score 4·27, p=0·0278), and left cerebral peduncle (Z score 4·05, p=0·0316). 
Improvements in ISNCSCI motor scores were associated with less white matter volume change encompassing the 
corticospinal tract at the level of the right internal capsule (Z score 4·01, p<0·0001).
Interpretation Extensive upstream atrophic and microstructural changes of corticospinal axons and sensorimotor 
cortical areas occur in the ﬁ rst months after spinal cord injury, with faster degenerative changes relating to poorer 
recovery. Structural volumetric and microstructural MRI protocols remote from the site of spinal cord injury could 
serve as neuroimaging biomarkers in acute spinal cord injury.
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Introduction
Acute trauma to the spinal cord leads to diﬀ erent 
degrees of sensorimotor and autonomic nerve damage, 
for which an eﬀ ective treatment is awaited. Patients 
with a spinal cord injury generally show little clinical 
recovery within the ﬁ rst year after injury1 and most are 
permanently disabled. Clinical recovery requires a 
degree of preservation of axonal tracts and suﬃ  cient 
myelination of fast conducting ﬁ bres.2 Understanding 
the sequence of structural and functional changes at 
the spinal and brain level—and deﬁ ning their eﬀ ects 
on clinical outcome—is key to development of evidence-
based rehabilitation therapy.3 Moreover, with the advent 
of clinical trials in this setting,4,5 a pressing need exists 
for in-vivo neuroimaging biomarkers that can reliably 
assess the extent of neural damage, elucidate the 
mechanisms of neural repair, and predict clinical 
outcome.6 
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Study of acute and progressive structural changes in 
human spinal cord injury is challenging because of the 
small number of patients with this disorder, the 
heterogeneity of spinal cord damage, and the diﬃ  culty 
of neuroimaging close to the lesion site in the presence 
of implants. Although prognostic indicators of 
neurological and functional recovery7 based on gross 
anatomical changes at the lesion site have been 
established with conventional MRI,8 their use as 
neuroimaging biomarkers is restricted (eg, because 
changes in the extent of spinal cord haemorrhage and 
swelling provide little information about the condition 
of the nerve ﬁ bre tracts). 
In chronic spinal cord injury, cross-sectional measures 
of the spinal cord and brain, such as cord area and voxel-
based morphometry (VBM) of cortical volume, have 
shown correlations between structural changes (ie, 
atrophy) and neurological deﬁ cits.9 However, study of 
cross-sectional samples of patients at a speciﬁ c timepoint 
is uninformative for assessment of degenerative (or 
neuroplastic) processes that manifest over time. These 
processes are characterised by structural changes at the 
microstructural (eg, myelination) and macrostructural 
(volume) level in speciﬁ c systems and tissues. 
Characterisation of the pattern of changes that aﬀ ect the 
myelin and axonal architecture might be crucial for the 
design and execution of clinical trials and for most 
appropriate use of rehabilitation therapies.
On the basis of preclinical work4,10 and MRI ﬁ ndings in 
chronic spinal cord injury,11–13 we postulated that 
microstructural and macrostructural changes would 
follow a speciﬁ c temporal and spatial pattern after acute 
spinal cord injury, and the extent of supraspinal 
morphological changes would be associated with clinical 
outcomes. Therefore, we used tensor-based morphometry 
(TBM), applied to longitudinal anatomical MRI data, to 
assess progression of volumetric changes after injury14 
and multiparametric mapping (MPM)15–17 to assess 
myelination changes as a marker of microstructure. 
Methods
Participants and study design
In our longitudinal study, we enrolled patients with acute 
traumatic spinal cord injury who were admitted 
consecutively to the University Hospital Balgrist (Zurich, 
Switzerland) between Sept 17, 2010, and Dec 31, 2012. 
Eligible patients had acute (within the past 2 months) 
traumatic spinal cord injury, without head or brain 
lesions associated with the spinal cord injury, pre-existing 
neurological disorders, medical disorders leading to 
functional impairment or mental illness, or 
contraindications to MRI. 
Patients underwent a comprehensive clinical assess-
ment, including the international standards for the 
neurological classiﬁ cation of spinal cord injury 
(ISNCSCI) protocol18 and the spinal cord independence 
measure (SCIM),19 at baseline and at 2 months, 6 months, 
and 12 months of follow-up. Both scales range from 0 to 
100, with 0 indicating no impairment and 100 indicating 
full impairment. At each timepoint, patients underwent a 
comprehensive MRI protocol. 
We also enrolled healthy individuals from the local 
area, who were invited to partake in MRI investigations, 
following the same schedule as the patients. All 
participants provided written informed consent before 
participation in the study, which was approved by the 
local Ethics Committee of Zurich (EK-2010-0271). 
Procedures
We scanned participants with a 3T Magnetom Verio MRI 
scanner (Siemens Healthcare, Erlangen, Germany) 
operated with a 16-channel receive head and neck coil. 
The MRI protocol consisted of assessment of three-
dimensional (3D) whole-brain (including brainstem and 
cervical cord [C1–C5]) structural volume data with 
an optimised20 high-resolution T1-weighted 3D 
Magnetization Prepared Rapid Acquisition Gradient-
Echo (MPRAGE) sequence21 at each visit and 
multiparametric mapping based on multiecho 3D fast 
low angle shot (FLASH) sequences at 12 months.22
For T1-weighted data, 176 sagittal partitions were 
acquired with an isotropic spatial resolution of 1 mm³ in a 
total scan time of 9·04 min. The imaging parameters were: 
ﬁ eld of view of 224 × 256 mm², matrix 224 × 256, repetition 
time of 24·20 ms, echo time of 4·18 ms, inversion time of 
960 ms, ﬂ ip angle of 9°, and readout bandwidth of 150 Hz 
per pixel. We checked all images for movement artifacts. 
The MPM protocol was based on the Siemens 3D FLASH 
product sequence with the following sequence para-
meters:17,23 We applied a repetition time of 25 ms and ﬂ ip 
angle of 23° to the T1-weighted images, a repetition time of 
25 ms and ﬂ ip angle of 4° for the proton density-weighted 
images, and a repetition time of 37 ms and ﬂ ip angle of 
9° for the magnetisation transfer (MT)-weighted images. 
MT weighting was achieved by an oﬀ -resonance 
radiofrequency pulse before non-selective excitation. 
Alternating gradient echoes were acquired at seven 
equidistant echo timepoints between 2·46 ms and 
17·22 ms for the MT-weighted acquisitions with one 
additional echo at time 19·68 ms for the T1-weighted and 
proton density-weighted acquisitions. Total scan time for 
the three 3D FLASH datasets was 23 min.
We used Jim 6·0 (Xinapse systems, Aldwincle, UK) for 
the measurement of cross-sectional spinal cord area. 
First, we extracted a series of ten contiguous reformatted 
axial slices (3 mm slice thickness) at the C2/C3 level 
based on a previously published method.23 The cross-
sectional cord area was then calculated automatically 
using an active-surface model.24
We used TBM, as implemented in SPM12 (University 
College London, London, UK), to estimate regional 
changes of brain volume over time for patients and 
controls.14 By use of groupwise-consistent 3D non-linear 
image registration, we longitudinally aligned the four 
For more on SPM12 see http://
www.ﬁ l.ion.ucl.ac.uk/spm
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MRI volumes for each participant, collected at baseline, 
2 months, 6 months, and 12 months, to their midpoint 
average14 to produce a Jacobian determinant map for each 
timepoint—relative to the midpoint average image—for 
each participant. The average images were subsequently 
aligned with the population mean, enabling the Jacobian 
diﬀ erence maps to be transformed (with Jacobian 
scaling) to the same standard (Montral Neurological 
Institute [MNI]) space.14 These aligned maps encoded the 
three-dimensional proﬁ les of longitudinal volumetric 
expansion and compression for each participant.
We used VBM to make voxel-wise comparisons of 
white matter and grey matter volume between groups of 
participants at 12 months.25 Brieﬂ y, the T1-weighted 
anatomical images were segmented into grey matter, 
white matter, and CSF with uniﬁ ed segmentation.26 For 
each participant, this procedure produced three images 
in the same space as the original anatomical image, in 
which each voxel was assigned a probability of being grey 
matter, white matter, or CSF. The grey matter and white 
matter segments were then warped into standard MNI 
space, representing the average of all the participants, 
with a diﬀ eomorphic non-linear image registration 
instrument implemented in SPM12 (Dartel).27 The grey 
matter volumes were scaled with the Jacobian 
determinants from the registration step (ie, modulation) 
Age at injury 
(years)
Injury ISNCSCI grade 
at baseline
Initial site of impairment 
(motor/sensory)
ISNCSCI motor score 
(maximum 100)
SCIM score 
(maximum 100)
Type Severity Baseline 12 months Baseline 12 months
1 19 Fall Complete A C5/C4 20 23 4 27
2 23 Fall Incomplete B C7/C6 42 67 23 70
3 70 Fall Incomplete B T10/T10 62 75 38 42
4 75 Fall Incomplete D T12/T12 100 NA* 60 NA*
5 44 Fall Incomplete D T11/T11 89 95 39 100
6 42 Fall Complete A C5/C5 23 25 1 37
7 71 Fall Incomplete B C7/C8 52 89 17 36
8 20 MVA Complete A C5/C5 21 23 4 34
9 30 MVA Incomplete B C7/C8 22 48 13 38
10 52 Fall Incomplete D T9/T9 98 98 47 100
11 42 MVA Incomplete D C5/C4 81 82 98 98
12 70 MVA Complete A T7/T7 50 50 29 45
13 52 MVA Incomplete B C6/C6 27 44 24 36
All patients were male, apart from patient 3 who was female. ISNCSCI=international standards for the neurological classiﬁ cation of spinal cord injury. SCIM=spinal cord 
independence measure. MVA=motor vehicle accident. *Not available because the patient died.
Table 1: Clinical and behavioural data for 13 patients with spinal cord injury
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Figure 1: Longitudinal changes in spinal cord area
(A) Change in cross-sectional spinal cord area at the C2/C3 level after injury in patients with spinal cord injury and in healthy controls. (B) Change in cross-sectional spinal cord area diﬀ ered signiﬁ cantly 
between patients and controls. Horizontal error bars show SE of the scan intervals and vertical error bars show SE for percentage change in cross-sectional spinal cord area. 
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to preserve the local tissue volumes. Finally, the volumes 
were smoothed with an isotropic Gaussian kernel with 
5 mm full width at half maximum. 
We used MT-weighted, proton density-weighted, and 
T1-weighted FLASH images to calculate the quantitative 
parameter maps of MT saturation and apparent 
longitudinal relaxation rate R1 (deﬁ ned as 1/T1) as 
described previously.17,22,28 We corrected R1 brain maps 
for radiofrequency transmit ﬁ eld inhomogeneities with 
UNICORT.22 By use of uniﬁ ed segmentation, the MT 
maps of each participant were segmented into grey 
matter, white matter, and CSF26 and transformed to 
standard MNI space—again with Dartel.27 Then, we 
warped the MT and corrected R1 maps to standard MNI 
space with the participant-speciﬁ c diﬀ eomorphic 
estimates from the Dartel procedure and smoothed 
with an isotropic Gaussian kernel with 5 mm full width 
at half maximum, while preserving the parameter 
values with the voxel-based quantiﬁ cation (VBQ) 
renormalisation.22 
Because our main focus was on degenerative changes 
of the sensorimotor system caused by trauma to the 
spinal cord,9 we created a binary mask from the MRI Atlas 
of Human White Matter29 derived from diﬀ usion imaging 
in MNI space to assess in the normalised images (also in 
MNI space) the volumetric and microstructural changes 
encompassing the corticospinal tracts. To assess grey 
matter changes in the cortex we extracted the bilateral 
primary motor (M1) and primary sensory (S1) cortices 
with the anatomy toolbox for SPM.30 
Statistical analysis 
We used Stata 12 to assess clinical recovery and spinal 
cord area change. We used regression models to 
estimate rates of change of spinal cord area (all 
participants) and clinical recovery (patients only), with 
the spinal cord area, clinical measure, or lesion level as 
response variable and time as predictor. For clinical 
measures, time was modelled on a log scale to 
accommodate non-linear recovery trajectories. A 
quadratic term in time was added to model non-linear 
changes in cord area with time. To compare rates of 
change of cord area between patients and controls, we 
included a group indicator and group × time interaction 
in the regression model. Age and sex terms and their 
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Figure 2: Longitudinal changes in grey and white matter volume shown by tensor-based morphometry
(A) Overlay of statistical parametric maps (uncorrected p<0·001, shown for descriptive purposes, masked by the union of the cranial corticospinal tract and the bilateral sensorimotor cortex) showing 
regions of volume changes in grey matter (in blue) and white matter (in red). (B) Illustration showing changes in white matter volume in the corticospinal tracts, at the level of the left internal capsule, 
in patients and healthy controls. Horizontal error bars show SE of the scan intervals and vertical error bars show SE for percentage change in spinal cord area.
Left Left
Figure 3: Changes at 12 months shown by voxel-wise analysis of microstructure and volume
Overlay of statistical parametric maps (uncorrected p<0·001, shown for descriptive purposes, masked by the union 
of the cranial corticospinal tract and the bilateral sensorimotor cortex) showing regions of reduced volume of grey 
and white matter (blue) in patients compared with controls at 12 month follow-up. The reductions in longitudinal 
relaxation rate R1 (yellow) and magnetisation transfer MT (red) in patients compared with controls at 12 month 
follow-up suggest changes in myelination.
Z score p value (FWE-
corrected)
Cluster extent 
(voxels)
x (mm) y (mm) z (mm)
Linear rate of atrophy
Right internal capsule 5·21 0·0081 2180 –19·5 –22·5 16·5
Left internal capsule 4·12 0·0004 1074 22·5 –25·5 12·0
Right cerebral peduncle 3·89 0·0302 56 –9·0 –15·0 –22·5
Left primary motor cortex 4·23 0·0410 442 –43·5 –13·5 39·0
Deceleration of rate of atrophy
Left internal capsule 4·88 0·0265 1094 –19·5 –22·5 16·5
Only clusters with signiﬁ cant rates of atrophy between patients and controls are shown for the tensor-based 
morphometry analysis. FWE=family wise error. 
Table 2: Progressive white and grey matter atrophy in patients with spinal cord injury
For more on the anatomy 
toolbox for SPM see http://
www.ﬁ l.ion.ucl.ac.uk/spm
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interaction with time were included to accommodate 
potential age or sex confounds. 
To assess longitudinal cortical changes over 12 months, 
we used statistical parametric mapping to test for 
regionally speciﬁ c changes in grey and white matter 
volume as determined by the TBM Jacobian. These data 
were modelled with (general linear) regression models 
comprising group indicators, age, and time. We expected 
that volume changes would depend non-linearly on time 
(ie, on the time elapsed between measurement and injury) 
because saturation and rebound eﬀ ects might occur. 
Thus, we modelled the time dependence of the volume 
with linear and quadratic terms as previously described. 
The constant term models a general oﬀ set (intercept), the 
linear term models volume changes with a constant rate 
of atrophy, and the quadratic term models changes with 
an accelerating and decelerating rate of atrophy. 
The model was ﬁ tted to every voxel in the regions of 
interest in the bilateral M1 and S1 cortices for grey matter 
volume and the cranial corticospinal tracts for white 
matter volume. We used t statistics to test for linear and 
quadratic volume changes over time. The t tests were one-
tailed and the associated p values of less than 0·05 were 
corrected for multiple comparisons with family-wise 
error correction within each region of interest, with 
Gaussian random ﬁ eld theory to accommodate non-
stationary spatial correlations among error terms.14 
To assess diﬀ erences in grey matter and white matter 
volume and myelination (MT and R1 maps) between 
patients and controls at 12 months, we used statistical 
parametric mapping and the T1-weighted 3D MPRAGE 
for VBM analyses and MPM data for VBQ analyses. Our 
regression models included group indicators, age, and 
total intracranial volume. We calculated total intracranial 
volume from the segmented grey matter, white matter, 
and CSF from the T1-weighted 3D MPRAGE scans for 
the VBM analysis and from the MT scans for the VBQ 
analysis. This analysis used the same regions of interest 
and statistical thresholds as in the TBM analysis. 
To examine associations between spinal cord area and 
clinical recovery in patients, regressions were done with 
clinical outcome at 12 months as response and change in 
cord area at 12 months as predictor. To assess associations 
between cortical volume changes and clinical recovery in 
time, we used the linear and quadratic coeﬃ  cients (ie, 
parameter estimates from the aforementioned regression 
models) as response variables and clinical covariates of 
interest (ISNCSCI motor score, SCIM score) and age as 
predictor variables to produce statistical parametric maps 
of regionally speciﬁ c associations. These associations were 
tested with F statistics and were regarded as signiﬁ cant if 
Z score p value 
(FWE-
corrected) 
Cluster 
extent 
(voxels)
x 
(mm)
y 
(mm)
z 
(mm)
M1 or S1 region of interest
Left
R1
M1 4·04 <0·001 169 –1·0 –24·0 56·0
M1 3·48 0·0469 30 –44·0 –13·0 43·0
S1 4·12 0·0009 45 –52·0 –16·0 46·0
S1 3·76 0·001 54 –58·0 –19·0 41·0
S1 4·09 0·0061 34 –32·0 –35·0 52·0
S1 3·84 0·0201 29 –33·0 –43·0 68·0
MT
M1 5·03 <0·001 89 –1·0 –24·0 54·0
M1 4·15 <0·001 168 –37·0 –17·0 43·0
M1 3·92 <0·001 96 –30·0 –25·0 54·0
S1 3·92 <0·001 310 –45·0 –17·0 35·0
S1 3·99 0·0027 38 –32·0 –35·0 52·0
S1 4·40 <0·001 66 –29·0 –41·0 56·0
VBM
M1 4·11 0·0398 235 –7·5 –37·5 73·5
Right
R1
M1 3·86 <0·001 137 50·0 –6·0 38·0
S1 4·19 <0·001 105 35·0 –41·0 56·0
S1 4·48 <0·001 139 55·0 –14·0 40·0
S1 3·95 0·0007 34 8·0 –32·0 78·0
S1 4·08 0·0026 46 46·0 –36·0 54·0
S1 4·02 0·0042 38 9·0 –46·0 76·0
S1 4·27 0·0124 44 59·0 –19·0 47·0
(Continues in next column)
Z score p value 
(FWE-
corrected) 
Cluster 
extent 
(voxels)
x 
(mm)
y 
(mm)
z 
(mm)
(Continued from previous column)
MT
M1 4·91 <0·001 164 3·0 –29·0 61·0
M1 4·85 <0·001 85 27·0 –28·0 59·0
M1 4·84 <0·001 76 34·0 –35·0 54·0
M1 4·73 <0·001 104 24·0 –28·0 58·0
S1 5·40 <0·001 819 48·0 –11·0 34·0
S1 4·73 <0·001 71 59·0 –6·0 29·0
S1 4·17 0·0304 34 59·0 –19·0 47·0
CST region of interest
Left
R1 3·88 <0·001 4033 –32·0 –34·0 28·0
VBM 4·49 0·0248 203 –6·0 –33 –58·5
Right
R1 (cluster 1) 3·58 <0·001 68 11·0 –43·0 –33·0
R1 (cluster 2) 3·41 0·0035 107 6·0 –43·0 –52·0
MT 4·10 0·0083 322 20·0 –40·0 51·0
Only clusters with signiﬁ cant diﬀ erences between patients and controls are 
shown for the VBM and MPM data (ie, MT and R1). FWE=family wise error. 
VBM=voxel-based morphometry. CST=corticospinal tract. MPM=multiparametric 
mapping. MT=magnetisation transfer. R1=longitudinal relaxation rate. 
M1=primary motor cortex. S1=primary sensory cortex. 
Table 3: Group analyses showing cortical changes both of atrophy and 
microstructure in patients compared with controls at 12 months
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p<0·05 (corrected for multiple comparisons as described 
previously). 
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. All authors had full access to all the 
data in the study and responsibility for the decision to 
submit for publication.
Results
We recruited 13 patients with acute traumatic spinal 
cord injury (12 men and one woman), with a mean age 
of 46·9 years (SD 20·2; table 1). We recruited 18 healthy 
participants (12 men and six women; mean age 
35·0 years [9·3]). 
Eight of 13 patients with a traumatic spinal cord injury 
had tetraplegia and ﬁ ve had paraplegia (table 1). Three 
patients with tetraplegia and one patient with paraplegia 
were classiﬁ ed as having complete spinal cord injury 
based on the ISNCSCI classiﬁ cation. 
From time of injury, the mean interval to the baseline 
scan was 35·48 days (SD 17·94), to the 2 month scan was 
77·08 days (16·88), to the 6 month scan was 177·75 days 
(24·81), and to the 12 month scan was 356·75 days 
(34·22). We included 31 datasets at baseline and 
30 datasets at 2 months, 6 months, and 12 months in the 
ﬁ nal analysis, meaning 30 (98%) of 31 participants 
completed follow-up. One patient missed the second scan 
owing to illness and another patient died 5 months after 
enrolment from a cause unrelated to spinal cord injury.
In the 12 months from baseline, patients recovered by 
5·27 points per log month (95% CI 1·91–8·63) on the 
ISNCSCI motor scores scale (p=0·002) and by 
10·93 points per log month (6·20–15·66) on the SCIM 
score scale (p<0·0001). Approximate linearity of recovery 
on the log time scale implies that the recovery rate is 
faster soon after the injury than it is later on. In particular, 
when ISNCSCI and SCIM score recovery were modelled 
on both raw time and log time as covariates, the raw time 
coeﬃ  cient lost signiﬁ cance (p=0·061 for ISNCSCI and 
p=0·137 for SCIM) whereas log time remained signiﬁ cant 
(p=0·0010 and p=0·0001), suggesting that log time ﬁ ts 
the recovery trajectory better than did raw time, and 
therefore that recovery is steeper in the ﬁ rst 6 months 
than it is after this point.
At baseline, spinal cord area was 3·7 mm² lower in 
patients with a spinal cord injury (mean 73·0 mm² 
[SD 6·8]) than it was in controls (mean 76·7 mm² [4·6]; 
p=0·089). Patients had a signiﬁ cantly greater rate of 
change of spinal cord area than did controls (patients 
decreasing by 0·46 mm² per month [95% CI 0·58–0·33] 
more than controls, p<0·0001; ﬁ gure 1). In patients, 
spinal cord area decreased by 0·41 mm² per month 
Figure 5: Correlation between brain atrophy and clinical outcome
(A) Overlay of statistical parametric maps (uncorrected p<0·001, shown for descriptive purposes; masked by the union of the cranial corticospinal tract) showing associations of volume changes with 
ISNCSCI motor score (blue) and SCIM score (red). (B) Rates of change in atrophy in patients with a SCIM score <50 and ≥50 at 12 months. Horizontal error bars show SE of the scan intervals and vertical 
error bars show SE for percentage change in white matter volume change of the corticospinal tract at the level of the internal capsule relative to baseline. SCIM=spinal cord independence measure. 
ISNCSCI=international standards for the neurological classiﬁ cation of spinal cord injury.
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(0·51–0·31, p<0·0001), whereas in controls the spinal 
cord area did not change substantially (increase of 
0·048 mm² per month –0·03 to 0·13, p=0·234; ﬁ gure 1). 
We did not detect any signiﬁ cant non-linear (quadratic) 
spinal cord atrophy (p=0·718).
At the cortical level, patients showed a signiﬁ cant 
diﬀ erence in rates of change of white matter volume in the 
cranial corticospinal tracts (ﬁ gure 2). These eﬀ ects were 
noted at the level of the internal capsule (right side Z score 
5·21, p=0·0081; left side Z score 4·12, p=0·0004) and the 
right cerebral peduncle (Z score 3·89, p=0·0302). The rate 
of atrophy decelerated (with a signiﬁ cant quadratic eﬀ ect) 
within the left internal capsule between 6 months and 
12 months follow-up (Z score 4·88, p=0·0265; ﬁ gure 2, 
table 2). Rates of cortical grey matter volume changes 
diﬀ ered between patients and controls in the left primary 
motor cortex (Z score 4·23, p=0·041). We did not detect 
any signiﬁ cant non-linear (quadratic) eﬀ ects for grey-
matter changes. 
Figure 3 shows the reduction in cortical grey matter 
volume and subcortical white matter volume in the 
corticospinal tracts at the level of the medulla oblongata at 
12 months in patients relative to controls. This reduction 
was paralleled by reductions of R1 and MT—which are 
myelin sensitive—within hand and leg areas of primary 
motor and primary sensory cortices and the corticospinal 
tracts. The reduction in R1 and MT overlapped with areas 
of the sensorimotor cortex and corticospinal tracts that 
showed progressive atrophy (table 3). 
Within the spinal cord, a smaller loss in area during 
12 months’ follow-up was associated with better SCIM 
score at 12 months (ﬁ gure 4). Within the brain, a smaller 
loss in corticospinal tract white matter volume over time 
was associated with better outcome at 12 months. 
Speciﬁ cally, improved ISNCSCI motor scores (Z score 
4·01, p<0·0001) and SCIM scores (Z score 4·30, p=0·0021) 
at 12 months were associated with decreased white matter 
volume changes at the level of the right internal capsule. 
In addition, an improved SCIM score was associated with 
decreased white matter volume change encompassing the 
corticospinal tracts at the level of the left internal capsule 
(Z score 4·27, p=0·0278) and left cerebral peduncle 
(Z score 4·05, p=0·0316; ﬁ gure 5, table 4). Lesion level was 
not associated with rate of atrophy (p=0·459).
Discussion
Our study showed that, in patients with acute spinal cord 
injury, a progressive and speciﬁ c pattern of structural 
neural change occurs rostral to the level of the lesion, akin 
to that reported in studies of animals (panel). As early as 
40 days, a pronounced reduction of spinal cord area occurs 
compared with controls, with a corresponding reduction 
in white matter volume of the cranial corticospinal tracts 
and grey matter volume in the sensorimotor cortex. 
Assessment of the underlying pathophysiology, with a 
myelin-sensitive MPM approach, supports the assumption 
that these volume changes relate to atrophy of myelinated 
axons and their cell bodies within grey matter of the 
sensorimotor cortices.11–13 Crucially, from a clinical 
perspective, a notable association exists between increased 
changes in spinal cord and brain structure and poor 
recovery. The ﬁ nding of a systematic degenerative pattern 
with time suggests that non-invasive MRI measures could 
be used for prediction of outcome, identiﬁ cation of 
patients most likely to beneﬁ t from diﬀ erent interventions, 
and as potential markers of treatment eﬀ ects of 
interventions (physical, drug, or cell-based therapies).
Z score p value (FWE-
corrected)
Cluster extent 
(voxels)
x (mm) y (mm) z (mm)
SCIM score
Right internal capsule 4·30 0·0021 539 18·0 –9·0 7·5
Left internal capsule
Cluster 1 4·27 0·0278 200 –27·0 –9·0 –1·5
Cluster 2 4·05 0·0439 57 –7·5 –15·0 –7·5
Left cerebral peduncle 4·05 0·0316 46 –9·0 –31·5 –22·5
ISNCSCI motor score
Right internal capsule 4·01 <0·001 725 16·5 –4·5 –4·5
Only clusters showing signiﬁ cant associations between clinical outcome and volumetric structural changes with time 
are shown. FWE=family-wise error. SCIM=spinal cord independence measure. ISNCSCI=international standards for the 
neurological classiﬁ cation of spinal cord injury.
Table 4: Structural correlates of clinical outcome at 12 months
Panel: Research in context
Systematic review
We searched PubMed for articles published in English between Jan 1, 1990, and Feb 28, 
2013, with the search term “spinal-cord injury” combined with speciﬁ c search terms that 
constituted the subheadings (eg, “acute”, “atrophy”, “MRI”, “rehabilitation”, 
“degeneration”, “functional recovery”). This search identiﬁ ed studies, ranging from 
changes at the molecular level in animal models of spinal cord injury to changes in 
macrostructure in people with spinal cord injury. In studies that are most closely related 
to this study, cross-sectional volumetric changes were assessed in the chronic phase11–13 
but not longitudinally. 
Interpretation
Previously, degenerative changes of the CNS, remote from spinal cord injury, were 
thought to occur slowly31,32 and relate to the degree of impairment. By use of repeat MRI 
scans, we showed that these structural changes occur early and progress with a speciﬁ c 
spatial and temporal pattern at the spinal and brain levels. These structural changes are 
assumed to be induced by retrograde degeneration of central motor nerve ﬁ bres along 
the myelinated corticospinal tract axons that over time results in shrinkage of the soma 
of corticospinal projecting neurons.32 Preservation of structural integrity, at the spinal 
and brain levels, was associated with improved neurological and functional outcomes 
during rehabilitation. These structural changes might be useful in reporting the eﬀ ects 
of interventions targeting neural repair and plasticity, and for optimisation of 
rehabilitation programmes. Therefore, if conﬁ rmed in other studies, structural 
volumetric and microstructural MRI protocols remote from the site of spinal cord injury 
could be considered as neuroimaging biomarkers for interventional studies, because 
they disclose spatially and temporally distinct neuropathological changes in the CNS, 
and complement clinical outcome measures during rehabilitation from acute spinal 
cord injury. 
Articles
880 www.thelancet.com/neurology   Vol 12   September 2013
Spinal cord and brain areas showed distinct temporal 
proﬁ les of changes in response to acute spinal cord 
injury. Spinal cord area decreased consistently by about 
7% (5 mm²) within the ﬁ rst year after injury. Because in 
the chronic disease state (14 years after injury) spinal 
cord area was shown to only be decreased by up to 30%,12 
an ongoing but slower decrease was to be expected in our 
patients. As with spinal cord area, corticospinal tract 
white matter volume showed a progressive decrease 
(>2% compared with controls) during the same period. 
By contrast with the spinal cord area, the rate of brain 
atrophy was non-linear with a marked deceleration after 
6 months. Crucially, myelin-sensitive MRI parameters15–17 
at 12 months (R1 and MT) were reduced within, but also 
beyond, atrophic areas. These ﬁ ndings are suggestive of 
retrograde degeneration of myelinated axons.10 Moreover, 
the grey matter volume in the leg area of primary motor 
cortex and white matter volume of the corticospinal tracts 
(at the level of the pyramids) were decreased to a similar 
extent as that observed in the chronic phase.12 The 
progressive pattern of spinal cord area and cranial 
corticospinal tract volume decrease within the ﬁ rst 
40 days corresponds to the time course of atrophy of 
myelinated axons undergoing retrograde degeneration—
as described in post-mortem human spinal cord injury 
tissue33 and animal models of spinal cord injury.10 The 
rate of spinal cord atrophy was unrelated to the level of 
the lesion, suggesting distant independent degenerative 
processes induced by trauma. Future longitudinal studies 
combining high resolution quantitative and functional 
neuroimaging might provide further insights into the 
mechanisms of degeneration and plasticity and their 
eﬀ ect on cortical reorganisation during the course of 
recovery and rehabilitation. 
Although imaging measures have been recognised as 
the most valuable in-vivo proxies for pathological changes 
in other neurological diseases, such as multiple sclerosis,6 
they are not well established in spinal cord injury. The 
paucity of MRI measures in spinal cord injury is, in part, 
due to the diﬃ  culty in assessment of changes at the 
lesion level, because of artifacts caused by implanted 
ﬁ xative devices. Therefore, we applied advanced MRI 
measures that have been used successfully in the ﬁ eld of 
multiple sclerosis to detect remote structural changes 
sensitively and accurately. Notably, we show progressive 
structural changes that were associated with neurological 
(ISNCSCI) and functional (SCIM) improvement. 
Speciﬁ cally, at 12 months, reduced atrophy of the spinal 
cord was associated with improved SCIM scores. In 
addition, patients with low volume change in white 
matter in the cranial corticospinal tract at the level of the 
internal capsule had improved outcomes on ISNCSCI 
motor and SCIM scores. In other words, patients with 
greater corticospinal tract integrity recovered greater 
muscle strength and had higher degrees of independence 
(by means of increased ISNCSCI motor and SCIM 
scores) than did patients with low corticospinal tract 
integrity. Notably, dynamic atrophic changes at the level 
of the internal capsule were associated with clinical scores 
in contrast to those of the ﬁ nal (ie, 12 months) decrease of 
white matter volume at the level of the medulla oblongata. 
This eﬀ ect might be due to statistical eﬀ ects (statistical 
power in a cross-sectional versus longitudinal sample) or 
to the fact that changes in volume at 12 months represent 
late stage eﬀ ects that are less sensitive to disease 
progression than dynamic readouts. These ﬁ ndings 
might be of value to advance the stratiﬁ cation of patients 
for selection of drug or rehabilitation strategies and to 
assess treatment eﬀ ects by comparing functional 
outcomes with morphometric changes.34 The opportunity 
to assess the eﬀ ectiveness of therapeutic interventions 
(drug or physical therapy) due to insights into dynamic 
degenerative processes might provide important guidance 
to optimise rehabilitation strategies.
Our study had some limitations. Only 13 patients were 
included in the study, because these were the only 
patients within the recruitment period who fulﬁ lled the 
rigorous inclusion criteria, although this number should 
be considered in the context of the enormous burden of 
the disease (in view of the acuteness and severity of the 
disorder). Despite this limitation, we showed robust 
changes because the study beneﬁ ted from a high 
compliance (98% completed follow-up) and methods 
that analysed all available datapoints over time. The fact 
that we noted signiﬁ cant eﬀ ects suggests that the 
underlying eﬀ ect sizes are large. Another limitation was 
that controls were an average of 12 years younger than 
were patients. However, we included age as a covariate 
in all the statistical models to exclude eﬀ ects related to 
age. In accordance with previously published work,35 we 
did not note any evidence in this sample that spinal cord 
area was associated with age. In this cohort, atrophy 
rates in the spinal cord and brain were not signiﬁ cantly 
associated with age, and estimates of rates of change 
were not materially altered by adjustment for this 
variable. Finally, our inferences about the underlying 
disease mechanisms need to be treated with caution, 
because VBQ and VBM are indirect markers and cannot 
directly probe underlying biological changes at the 
microscopic level. However, histopathological studies 
have revealed a strong association between changes in 
myelination and MT and R1 values36 and therefore 
changes in myelinated axons can be reasonably assumed 
to contribute to atrophic changes observed within the 
ﬁ rst year after spinal cord injury. 
To our knowledge, this is the ﬁ rst in-vivo study to 
disclose acute and progressive structural changes along 
the neuroaxis after trauma to the spinal cord in human 
beings. Notably, decreased rates of atrophy were 
associated with improved clinical outcome. 
Thus, neuroimaging protocols can reliably capture 
progressive structural changes at the microstructural and 
macrostructural levels, and these changes are associated 
with clinical improvement. Their high sensitivity to 
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change and clinical outcome might support their use as 
neuroimaging biomarkers to help develop evidence-
based rehabilitation therapy and to track changes induced 
by treatment in trials promoting spinal cord repair. 
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